Company intelligence
Alcimed
We explore and develop your uncharted territories.
About Alcimed
Founded in 1993, Alcimed is an Innovation and New Business consulting firm specialized in sectors driven by innovation : life sciences (biotech, healthcare, food), energy, environment, chemicals, cosmetics, materials, building, transportation, aeronautics, space and defence. Our purpose is to help both private and public decision-makers exploring and developing their uncharted territories: new technologies, new offers, new geographies, possible futures, and new ways to innovate. Alcimed's clients are : - Industrial leaders - Start-ups and SMEs - Private Equity players and Public institutions. Our team is made up of 200 highly-qualified, multicultural and passionate individuals with a dual culture in science/technology and business. We have 7 offices in 5 countries : France, Germany, Italy, Singapore and the USA. Want to know more? https://www.alcimed.com
Verified activity
Signals from Alcimed
4 published signals
Presence & Recognition
Alcimed is providing access to its market research and strategy for healthcare in France and internationally.
Reported by Alcimed
Presence & Recognition
Alcimed's explorateur en chef Rodolphe Renac spoke in the BiotechFinances - Medtech - Santé Numérique - DTx - Intelligence Artificielle magazine about accelerating AI in pharmaceuticals.
Reported by Alcimed
Research & Knowledge
Alcimed provides expertise in personalized medicine across research, strategy R&D, patient needs analysis, and market access.
Reported by Alcimed
Legal & Regulatory
Alcimed announced that the approval of the Ryoncil™ allogeneic therapy was granted by the FDA in the United States in 2026, marking a milestone for the field.
Reported by Alcimed